BTIG Downgrades Akoya Biosciences Inc (AKYA) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Akoya Biosciences Reports Second Quarter 2024 Financial Results
August 5, 2024 4:00 PM EDTMARLBOROUGH, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (Akoya), The Spatial Biology Company®, today announced its financial results for the second quarter ending June 30, 2024.
Our second-quarter revenue showed a strong rebound with 26% sequential top-line growth and a stable year-over-year performance, said Brian McKelligon, CEO of Akoya Biosciences. We believe that Akoyas platforms are poised to lead the spatial biology market from... More
